Doron Breen serves as Executive at NeurogesX Inc, where they oversee executive responsibilities. Since joining the company, Doron Breen has executed 56 insider transactions totaling $5.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 21, 2009 involved purchasing 2,033 shares valued at $16.3K.
Doron Breen currently holds 270,498 shares of NeurogesX Inc (NGSX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Doron Breen has been a net buyer of NGSX stock. They have purchased $5.2M and sold $219.6K worth of shares.
Doron Breen's most recent insider trade was on Sep 21, 2009, when they purchased 2,033 shares at $8.00 per share.
Get notified when new Form 4 filings are submitted
| $8.36 |
| Discretionary |
| Sep 16, 2009 | NGSX | $87.7K | Purchase | 10,466 | $8.38 | Discretionary |
| Sep 15, 2009 | NGSX | $34.1K | Purchase | 4,263 | $8.00 | Discretionary |
| Sep 15, 2009 | NGSX | $136.1K | Purchase | 17,055 | $7.98 | Discretionary |
| Sep 11, 2009 | NGSX | $676.7K | Purchase | 88,000 | $7.69 | Discretionary |